{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T06:09:57Z","timestamp":1760249397542,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12944-018-0667-y","type":"journal-article","created":{"date-parts":[[2018,2,5]],"date-time":"2018-02-05T09:08:22Z","timestamp":1517821702000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Sex disparity in the management and outcomes of dyslipidemia of diabetic patients in the Arabian Gulf: findings from the CEPHEUS study"],"prefix":"10.1186","volume":"17","author":[{"given":"Ibrahim","family":"Al-Zakwani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"Al-Mahruqi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"Al-Rasadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Shehab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wael","family":"Al Mahmeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Arafah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali T.","family":"Al-Hinai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omer","family":"Al Tamimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Al Awadhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raul D.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,5]]},"reference":[{"key":"667_CR1","unstructured":"Word Health Organization. Global Report on Diabetes. Available at: \n                    http:\/\/apps.who.int\/iris\/bitstream\/10665\/204871\/1\/9789241565257_eng.pdf\n                    \n                  . Accessed 11 July 2017."},{"key":"667_CR2","unstructured":"International Diabetes Federation. Diabetes prevalence (% of population ages 20\u201379). Available at: \n                    http:\/\/data.worldbank.org\/indicator\/SH.STA.DIAB.ZS?order=wbapi_data_value_2015+wbapi_data_value+wbapi_data_value-first&sort=desc\n                    \n                  . Accessed 11 July 2017."},{"key":"667_CR3","doi-asserted-by":"publisher","first-page":"653789","DOI":"10.1155\/2013\/653789","volume":"2013","author":"AS Matheus","year":"2013","unstructured":"Matheus AS, Tannus LR, Cobas RA, Palma CC, Negrato CA, Gomes MB. Impact of diabetes on cardiovascular disease: an update. Int J Hypertens. 2013;2013:653789.","journal-title":"Int J Hypertens"},{"key":"667_CR4","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1001\/archinte.163.14.1735","volume":"163","author":"S Natarajan","year":"2003","unstructured":"Natarajan S, Liao Y, Cao G, Lipsitz SR, DL MG. Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease. Arch Intern Med. 2003;163:1735\u201340.","journal-title":"Arch Intern Med"},{"key":"667_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1136\/bmj.38678.389583.7C","volume":"332","author":"R Huxley","year":"2006","unstructured":"Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ. 2006;332:73\u20138.","journal-title":"BMJ"},{"key":"667_CR6","unstructured":"Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering: randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin survival study (4S). Lancet. 1994;344:1383\u20139."},{"key":"667_CR7","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1001\/jama.292.11.1307","volume":"292","author":"JA de Lemos","year":"2004","unstructured":"de Lemos JA, Blazing MA, Wiviott SD, et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the a to Z trial. JAMA. 2004;292:1307\u201316.","journal-title":"JAMA"},{"key":"667_CR8","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1136\/bmj.38793.468449.AE","volume":"332","author":"J Costa","year":"2006","unstructured":"Costa J, Borges M, David C, Carneiro AV. Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials. BMJ. 2006;332:1115\u201324.","journal-title":"BMJ"},{"key":"667_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12916-016-0550-5","volume":"14","author":"FD Hobbs","year":"2016","unstructured":"Hobbs FD, Banach M, Mikhailidis DP, Malhotra A, Capewell S. Is statin-modified reduction in lipids the most important preventive therapy for cardiovascular disease? A pro\/con debate. BMC Med. 2016;14:4.","journal-title":"BMC Med"},{"key":"667_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2174\/1570161114666161003095139","volume":"15","author":"I Al-Zakwani","year":"2017","unstructured":"Al-Zakwani I, Shehab A, Al-Hinai AT, et al. Gender disparity in lipid target acheivements in high and very high atherosclerotic cardiovascular disease risk patients in the Arabian gulf. Curr Vasc Pharmacol. 2017;15:51\u20138.","journal-title":"Curr Vasc Pharmacol"},{"key":"667_CR11","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.ahj.2006.05.013","volume":"152","author":"BJ Ansell","year":"2006","unstructured":"Ansell BJ, Fonarow GC, Maki KC, et al. Reduced treatment success in lipid management among women with coronary heart disease or risk equivalents: results of a national survey. Am Heart J. 2006;152:976\u201381.","journal-title":"Am Heart J"},{"key":"667_CR12","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.ahj.2009.08.009","volume":"158","author":"RD Santos","year":"2009","unstructured":"Santos RD, Waters DD, Tarasenko L, et al. Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: the lipid treatment assessment project (L-TAP) 2. Am Heart J. 2009;158:860\u20136.","journal-title":"Am Heart J"},{"key":"667_CR13","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1136\/hrt.2010.196170","volume":"96","author":"J Dallongevillle","year":"2010","unstructured":"Dallongevillle J, De Bacquer D, Heidrich J, et al. Gender differences in the implementation of cardiovascular prevention measures after an acute coronary event. Heart. 2010;96:1744\u20139.","journal-title":"Heart"},{"key":"667_CR14","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ijge.2013.03.002","volume":"7","author":"CY Chen","year":"2013","unstructured":"Chen CY, Chuang SY, Fang CC, et al. Gender difference in statin intervention on blood lipid control among patients with coronary heart disease. Int J Gerontol. 2013;7:116\u201321.","journal-title":"Int J Gerontol"},{"key":"667_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1476-511X-11-59","volume":"11","author":"R Zhang","year":"2012","unstructured":"Zhang R, Zhao L, Liang L, et al. Factors explaining the gender disparity in lipid-lowering treatment goal attainment rate in Chinese patients with statin therapy. Lipids Health Dis. 2012;11:59.","journal-title":"Lipids Health Dis"},{"key":"667_CR16","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/clc.20514","volume":"32","author":"X Li","year":"2009","unstructured":"Li X, Xu Y, Li J, et al. The gender differences in baseline characteristics and statin intervention among outpatients with coronary heart disease in China: the China cholesterol education program. Clin Cardiol. 2009;32:308\u201314.","journal-title":"Clin Cardiol"},{"key":"667_CR17","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.5551\/jat.21_Sup.1-S20","volume":"21","author":"CY Chen","year":"2014","unstructured":"Chen CY, Chuang SY, Fang CC, et al. Gender disparities in optimal lipid control among patients with coronary artery disease. J Atheroscler Thromb. 2014;21:S20\u20138.","journal-title":"J Atheroscler Thromb"},{"key":"667_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1258\/shorts.2011.011019","volume":"2","author":"L Alhyas","year":"2011","unstructured":"Alhyas L, McKay A, Balasanthiran A, Majeed A. Prevalences of overweight, obesity, hyperglycaemia, hypertension and dyslipidaemia in the Gulf: systematic review. JRSM Short Rep. 2011;2:55.","journal-title":"JRSM Short Rep"},{"key":"667_CR19","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1177\/0003319713512414","volume":"65","author":"M Arafah","year":"2014","unstructured":"Arafah M, Al-Hinai AT, Al Mahmeed WA, et al. Centralized pan-Middle East survey on the Undertreatment of hypercholesterolemia: results from the CEPHEUS study in Arabian gulf countries. Angiology. 2014;65:919\u201326.","journal-title":"Angiology"},{"key":"667_CR20","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jacl.2014.07.007","volume":"8","author":"TA Jacobson","year":"2014","unstructured":"Jacobson TA, Ito MK, Maki KC, et al. National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 \u2013 executive summary. J Clin Lipidol. 2014;8:473\u201388.","journal-title":"J Clin Lipidol"},{"key":"667_CR21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1093\/oxfordjournals.aje.a113284","volume":"115","author":"S Lemeshow","year":"1982","unstructured":"Lemeshow S, Hosmer DW Jr. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol. 1982;115:92\u2013106.","journal-title":"Am J Epidemiol"},{"key":"667_CR22","first-page":"69","volume":"11","author":"DP Nau","year":"2005","unstructured":"Nau DP, Mallya U. Sex disparity in the management of dyslipidemia among patients with type 2 diabetes mellitus in a managed care organization. Am J Manag Care. 2005;11:69\u201373.","journal-title":"Am J Manag Care"},{"key":"667_CR23","doi-asserted-by":"publisher","first-page":"S176","DOI":"10.1016\/j.whi.2011.04.009","volume":"21","author":"VG Vimalananda","year":"2011","unstructured":"Vimalananda VG, Miller DR, Palnati M, Christiansen CL, Fincke BG. Gender disparities in lipid-lowering therapy among veterans with diabetes. Womens Health Issues. 2011;21:S176\u201381.","journal-title":"Womens Health Issues"},{"key":"667_CR24","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/S1049-3867(02)00136-6","volume":"12","author":"MS Biswas","year":"2002","unstructured":"Biswas MS, Calhoun PS, Bosworth HB, Bastian LA. Are women worrying about heart disease? Womens Health Issues. 2002;12:204\u201311.","journal-title":"Womens Health Issues"},{"key":"667_CR25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1053\/hj.1998.v136.88874","volume":"136","author":"RJ Goldberg","year":"1998","unstructured":"Goldberg RJ, O\u2019Donnell C, Yarzebski J, Bigelow C, Savageau J, Gore JM. Sex differences in symptom presentation associated with acute myocardial infarction: a population-based perspective. Am Heart J. 1998;136:189\u201395.","journal-title":"Am Heart J"},{"key":"667_CR26","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1161\/01.CIR.0000154568.43333.82","volume":"111","author":"L Mosca","year":"2005","unstructured":"Mosca L, Linfante AH, Benjamin EJ, et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation. 2005;111:499\u2013510.","journal-title":"Circulation"},{"key":"667_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/11584380-000000000-00000","volume":"34","author":"SD Maggo","year":"2011","unstructured":"Maggo SD, Kennedy MA, Clark DW. Clinical implications of pharmacogenetic variation on the effects of statins. Drug Saf. 2011;34:1\u201319.","journal-title":"Drug Saf"},{"key":"667_CR28","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/0026-0495(93)90066-W","volume":"42","author":"R Carmena","year":"1993","unstructured":"Carmena R, Roederer G, Mailloux H, Lussier-Cacan S, Davignon J. The response to lovastatin treatment in patients with heterozygous familial hypercholesterolemia is modulated by apolipoprotein E polymorphism. Metabolism. 1993;42:895\u2013901.","journal-title":"Metabolism"},{"key":"667_CR29","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ijcard.2016.09.075","volume":"225","author":"M Banach","year":"2016","unstructured":"Banach M, Stulc T, Dent R, Toth PP. Statin non-adherence and residual cardiovascular risk: there is need for substantial improvement. Int J Cardiol. 2016;225:184\u201396.","journal-title":"Int J Cardiol"},{"key":"667_CR30","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.jacc.2017.07.752","volume":"70","author":"RS Rosenson","year":"2017","unstructured":"Rosenson RS, Baker S, Banach M, et al. Optimizing cholesterol treatment in patients with muscle complaints. J Am Coll Cardiol. 2017;70:1290\u2013301.","journal-title":"J Am Coll Cardiol"},{"key":"667_CR31","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.ahj.2013.02.011","volume":"165","author":"J Lewey","year":"2013","unstructured":"Lewey J, Shrank WH, Bowry ADK, Kilabuk E, Brennan TA, Choudhry NK. Gender and racial disparities in adherence to statin therapy: a meta analysis. Am Heart J. 2013;165:665\u201378.e1.","journal-title":"Am Heart J"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-018-0667-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T19:35:38Z","timestamp":1549308938000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-018-0667-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,5]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["667"],"URL":"https:\/\/doi.org\/10.1186\/s12944-018-0667-y","relation":{},"ISSN":["1476-511X"],"issn-type":[{"type":"electronic","value":"1476-511X"}],"subject":[],"published":{"date-parts":[[2018,2,5]]},"assertion":[{"value":"3 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study complied with the Declaration of Helsinki. The study had approval from the internal review bodies\/ethics committees of each participating institution in the each of the Arabian Gulf countries. Informed written consent was obtained from all patients enrolled in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"RDS has received honoraria related to consulting, research and or speaker activities from: Amgen, Astra Zeneca, Biolab, Boehringer-Ingleheim, Eli-Lilly, Kowa, Merck, Pfizer, Sanofi\/Regeneron and Procaps. The other authors disclose that they have no significant relationships with or financial interests in any commercial companies related to this study or article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"25"}}